BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19351367)

  • 21. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.
    Akishima-Fukasawa Y; Nakanishi Y; Ino Y; Moriya Y; Kanai Y; Hirohashi S
    Am J Clin Pathol; 2009 Aug; 132(2):202-10; quiz 307. PubMed ID: 19605814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44s expression is associated with improved survival in soft tissue sarcoma.
    Peiper M; Sato T; Zurakowski D; Eisenberger C; Heinecke A; Hosch S; Knoefel WT
    Anticancer Res; 2004; 24(2C):1053-6. PubMed ID: 15154622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
    Bendardaf R; Algars A; Elzagheid A; Korkeila E; Ristamäki R; Lamlum H; Collan Y; Syrjänen K; Pyrhönen S
    Oncol Rep; 2006 Oct; 16(4):741-6. PubMed ID: 16969488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.
    Ross JS; Sheehan CE; Williams SS; Malfetano JH; Szyfelbein WM; Kallakury BV
    Am J Clin Pathol; 2001 Jul; 116(1):122-8. PubMed ID: 11447742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD44s and CD44 splice variants in human melanoma.
    Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
    Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of chicken ovalbumin upstream promoter-transcription factor II expression in human colorectal cancer.
    Shin SW; Kwon HC; Rho MS; Choi HJ; Kwak JY; Park JI
    Oncol Rep; 2009 Jan; 21(1):101-6. PubMed ID: 19082449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
    Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
    Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
    Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
    Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
    Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.